Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.
Both human immunodeficiency virus (HIV) and illicit drug addiction remain major health problems not only in the United States but all over globe. The effect of drug addiction on HIV/AIDS (acquired immunodeficiency syndrome) has been somewhat underexplored. However, in United States more than one fourth of HIV-positive individuals are injection drug users. Opiates are known to negatively affect the immune system, and therefore may have deleterious effects on progression of disease among HIV-infected individuals. This review discusses the effects of opiates on immune system as well as its effect on HIV replication and AIDS progression. In addition, the effects of opiates on disease progression in non-human primate model of AIDS is presented with at least one possible reason for rapid disease progression in multi-virus the challenge model.
Noel
Richard J
RJ
Ponce School of Medicine, Ponce, Puerto Rico.
Rivera-Amill
Vanessa
V
Buch
Shilpa
S
Kumar
Anil
A
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000503:physiopathology / Q000821:virology; D000818:Animals; D004195:Disease Models, Animal; D018450:Disease Progression; D007107:Immune System / Q000187:drug effects* / Q000821:virology*; D009294:Narcotics / Q000494:pharmacology; D009293:Opioid-Related Disorders / Q000150:complications; D011323:Primates / Q000821:virology*
D009294:Narcotics
Adv Exp Med Biol. 1993;335:35-9
8237605
J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91
18040783
AIDS Res Hum Retroviruses. 2006 Aug;22(8):817-23
16910840
Front Biosci. 2005 May 01;10:1666-77
15769657
J Virol. 2000 Dec;74(24):11858-72
11090186
Virology. 2006 Mar 1;346(1):127-38
16313937
J Pharmacol Exp Ther. 2003 Dec;307(3):1158-62
14560041
Am J Ther. 2004 Sep-Oct;11(5):354-65
15356431
Biochem Biophys Res Commun. 1993 Sep 30;195(3):1165-73
8216245
Adv Exp Med Biol. 2003;521:98-105
12617568
Virology. 2006 Jun 5;349(2):440-52
16643974
J Leukoc Biol. 2005 Sep;78(3):772-6
16000393
Virology. 2007 Feb 20;358(2):373-83
17011009
J Virol. 2004 Oct;78(20):11425-8
15452267
J Infect Dis. 2000 Apr;181(4):1350-8
10762566
Adv Exp Med Biol. 2001;493:127-35
11727758
Virology. 2006 Oct 10;354(1):192-206
16876224
Adv Exp Med Biol. 1995;373:1-9
7668139
Neurology. 1998 Jun;50(6):1814-20
9633733
Adv Exp Med Biol. 1993;335:21-8
8237597
J Neuroimmunol. 2004 Apr;149(1-2):90-100
15020069
J Virol. 1998 May;72(5):4478-84
9557745
Science. 1995 Nov 10;270(5238):988-91
7481804
J Investig Med. 2002 Nov;50(6):435-42
12425430
J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S78-83
12394786
J Neuroimmune Pharmacol. 2008 Mar;3(1):12-25
18247128
J Neuroimmunol. 1998 Mar 15;83(1-2):77-87
9610676
J Infect Dis. 2002 Jan 1;185(1):118-22
11756991
J Neuroimmunol. 1994 Mar;50(2):167-75
8120138
AIDS. 1990 Sep;4(9):869-73
2174676
J Infect Dis. 2002 Jun 15;185(12):1826-9
12085334
FEMS Immunol Med Microbiol. 2006 Aug;47(3):330-42
16872369
Brain. 1998 Nov;121 ( Pt 11):2043-52
9827765
Adv Exp Med Biol. 1996;402:43-51
8787642
Clin Infect Dis. 2005 Oct 1;41(7):1027-34
16142670
AIDS Res Hum Retroviruses. 2006 Jan;22(1):114-9
16438654
Pediatr Res. 2003 Aug;54(2):282-8
12736382
Crit Rev Immunol. 1996;16(2):109-44
8879941
AIDS Res Hum Retroviruses. 2004 Jun;20(6):684-6
15242547
Virology. 2002 Mar 30;295(1):133-46
12033772
Virology. 2007 Mar 15;359(2):397-404
17064752
Cell. 1991 May 17;65(4):651-62
2032289
AIDS. 1994 Mar;8(3):339-43
7913328
Adv Exp Med Biol. 1993;335:181-8
8237594
J Pharmacol Exp Ther. 1993 Oct;267(1):9-15
7693915
J Virol. 1998 Mar;72(3):2509-15
9499115
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6326-30
9600964